Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis)
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm efficacy and safety when administering lamivudine
tablet alone in subjects with hepatitis B virus-induced liver cirrhosis.